Funding Received
$35.5 Million in 3 Rounds from 7 Investors
Most Recent Funding
$25.5 Million Series B on July 14, 2014
Headquarters:
Toronto, ON
Description:
Xagenic is a molecular diagnostics company developing on-demand molecular testing, facilitating faster treatment decisions for patients.
Founders:
Shana Kelley
Categories:
Biotechnology
Website:
http://www.xagenic.com

Company Details

Update
Employees:
2 in CrunchBase

Xagenic Inc., a Toronto, Canada-based molecular diagnostics company developing a new technology for decentralized, rapid diagnostic testing and a true point-of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs. Xagenic has adapted this technology to permit rapid, enzyme-free detection of nucleic acids from clinical samples.

We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.

Current Team (2)

Update

Board Members and Advisors (1)

Update

Investors (7)

Update

Offices/Locations (1)

Update
  • Headquarters

    55 York Street

    Suite 1000

    Toronto, ON M5J 1R7

    CAN